Diabetes and Its Impact on Cardiogenic Shock Outcomes in Acute Myocardial Infarction with Polyvascular Disease: A Comparative Analysis
- PMID: 39200364
- PMCID: PMC11351229
- DOI: 10.3390/biomedicines12081900
Diabetes and Its Impact on Cardiogenic Shock Outcomes in Acute Myocardial Infarction with Polyvascular Disease: A Comparative Analysis
Abstract
Background: Diabetes mellitus (DM) significantly impacts cardiovascular outcomes, particularly in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS). The presence of polyvascular disease further complicates the prognosis due to the increased burden of atherosclerosis and comorbidities. This study was designed to investigate the combined impact of DM and polyvascular disease on outcomes in patients with AMI and CS.
Method: Using the National Inpatient Sample database, we analyzed 39,140 patients with AMI complicated by CS and known polyvascular disease. The patients were stratified by diabetes status. The study assessed in-hospital major adverse cardiovascular and cerebrovascular events (MACCE), mortality, cerebrovascular accident (CVA) and major bleeding. Multivariable logistic regression models were used to examine the association between in-hospital outcomes and diabetes, adjusting for baseline differences.
Results: Of the study population, 54% had DM. The patients with DM were younger (69.5 vs. 72.1 years, p < 0.001) and more likely to be female (36.7% vs. 34.2%, p < 0.001). After adjustment, the patients with DM showed a 17% increased mortality risk (aOR 1.17, 95% CI: 1.11-1.23, p < 0.001) and a higher risk of major adverse cardiovascular and cerebrovascular events (aOR 1.05, 95% CI: 1.01-1.10, p = 0.020).
Conclusions: DM significantly impacts outcomes in patients with AMI complicated by CS and polyvascular disease, leading to increased mortality risk, longer hospital stays, and higher healthcare costs. These findings underscore the need for targeted interventions and specialized care strategies for this high-risk population.
Keywords: acute myocardial infarction; cardiogenic shock; diabetes mellitus; outcomes; poly-vascular disease.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Comparative analysis of cardiogenic shock outcomes in acute myocardial infarction with polyvascular disease.Am Heart J Plus. 2024 Aug 31;46:100452. doi: 10.1016/j.ahjo.2024.100452. eCollection 2024 Oct. Am Heart J Plus. 2024. PMID: 39319104 Free PMC article.
-
Association of Diabetes Mellitus and Its Types with In-Hospital Management and Outcomes of Patients with Acute Myocardial Infarction.Cardiovasc Revasc Med. 2023 Jul;52:16-22. doi: 10.1016/j.carrev.2023.02.008. Epub 2023 Feb 24. Cardiovasc Revasc Med. 2023. PMID: 36854639
-
Seasonal variation and prognosis in patients with acute myocardial infarction complicated by cardiogenic shock.Heliyon. 2024 Apr 24;10(9):e30078. doi: 10.1016/j.heliyon.2024.e30078. eCollection 2024 May 15. Heliyon. 2024. PMID: 38720697 Free PMC article.
-
Clinical Outcomes of Acute Myocardial Infarction Hospitalizations With Systemic Lupus Erythematosus: An Analysis of Nationwide Readmissions Database.Curr Probl Cardiol. 2022 Nov;47(11):101086. doi: 10.1016/j.cpcardiol.2021.101086. Epub 2021 Dec 20. Curr Probl Cardiol. 2022. PMID: 34936910 Review.
-
Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment.Curr Cardiol Rep. 2024 Jun;26(6):505-520. doi: 10.1007/s11886-024-02063-0. Epub 2024 May 14. Curr Cardiol Rep. 2024. PMID: 38743352 Review.
Cited by
-
Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease - a secondary analysis of the randomized TWENTE trials.Int J Cardiol Heart Vasc. 2025 Jul 6;59:101741. doi: 10.1016/j.ijcha.2025.101741. eCollection 2025 Aug. Int J Cardiol Heart Vasc. 2025. PMID: 40687396 Free PMC article.
References
-
- Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., Mitch W., Smith S.C., Jr., Sowers J.R. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–1146. doi: 10.1161/01.CIR.100.10.1134. Erratum in Circulation 2000, 101, 1629–1631. - DOI - PubMed
-
- Samsky M.D., Mentz R.J., Stebbins A., Lokhnygina Y., Aday A.W., Pagidipati N.J., Jones W.S., Katona B.G., Patel M.R., Holman R.R., et al. Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial. Atherosclerosis. 2021;338:1–6. doi: 10.1016/j.atherosclerosis.2021.10.011. - DOI - PMC - PubMed
-
- Gutierrez J.A., Scirica B.M., Bonaca M.P., Steg P.G., Mosenzon O., Hirshberg B., Im K., Raz I., Braunwald E., Bhatt D.L. Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial) Am. J. Cardiol. 2019;123:145–152. doi: 10.1016/j.amjcard.2018.09.014. - DOI - PubMed
LinkOut - more resources
Full Text Sources